News
Corporate
-
Group Company
Corporate
June 21, 2023
-
Taisho Pharmaceutical and Biolinq Announce Strategic Collaboration and Exclusive License Agreement in Japan
-
Group Company
Corporate
November 24, 2022
-
Transfer and Future Marketing of Osteoporosis Agent Bonviva in Japan
-
Group Company
Corporate
April 14, 2022
-
Former All Blacks players Richard McCaw and Daniel Carter appointed Lipovitan Ambassadors
-
Group Company
Corporate
October 8, 2021
-
Taisho Pharmaceutical appointed as Premium Global Partner of New Zealand Rugby
-
Group Company
Corporate
June 30, 2021
-
Taisho and Ancora Bio sign exclusive license agreement for the development, manufacturing, and commercialization of selective vasopressin V1b receptor antagonist, TS-121, worldwide
-
Group Company
Corporate
June 24, 2021
-
Taisho Pharmaceutical appointed as Official Supplier of Rugby World Cup France 2023
-
Holdings
Corporate
May 14, 2021
-
Notice Concerning the Execution of the Share Exchange Agreement to Make Biofermin Pharmaceutical Co., Ltd. a Wholly-owned Subsidiary of Taisho Pharmaceutical Holdings Co., Ltd.
-
Group Company
Corporate
January 22, 2021
-
Taisho and Chugai Terminate the Co-Marketing Agreement of Edirol®,a Treatment for Osteoporosis
-
Holdings
Corporate
August 31, 2020
-
Notice Concerning the Termination of the Agreement Between Taisho Pharmaceutical Co., Ltd. and Takeda Pharmaceutical Co., Ltd. on the Distribution of Prescription Drugs of Biofermin Pharmaceutical Co., Ltd.
-
Holdings
Corporate
June 26, 2020
-
Notice Concerning Issuance of Stock Options (Stock Acquisition Rights)
-
Holdings
Corporate
July 30, 2019
-
Notice Concerning Determination of Details of Stock Options (Stock Acquisition Rights)
-
Holdings
Corporate
July 2, 2019
-
Taisho Completed Procedures for the Acquisition of UPSA SAS
-
Holdings
Corporate
June 27, 2019
-
Notice Concerning Issuance of Stock Options (Stock Acquisition Rights)
-
Holdings
Corporate
May 20, 2019
-
Duoc Hau Giang Pharmaceutical JSC became a consolidated subsidiary of Taisho
-
Holdings
Corporate
April 18, 2019
-
Notice Regarding the Result of the Tender Offer for Shares of Duoc Hau Giang Pharmaceutical JSC
-
Holdings
Corporate
February 28, 2019
-
Notice Regarding the Tender Offer for Shares of Duoc Hau Giang Pharmaceutical JSC
-
Holdings
Corporate
January 30, 2019
-
Notice of Change in a Sub-subsidiary
-
Holdings
Corporate
December 19, 2018
-
Taisho Agreed To Acquire UPSA SAS, A French Pharmaceutical Manufacturer, and its Business Assets, Owned by Bristol-Myers Squibb Company
-
Holdings
Corporate
October 1, 2018
-
Notice of Termination of Business Alliance with FUJIFILM Holdings Corporation and TOYAMA CHEMICAL CO., LTD. and Change of the System for Sales of Ethical Pharmaceuticals
-
Holdings
Corporate
October 1, 2018
-
Notice of Change of Trade Name of Subsidiary
-
Holdings
Corporate
August 31, 2018
-
Results of Early Retirement Program
-
Holdings
Corporate
August 2, 2018
-
Notice Concerning Determination of Details of Stock Options (Stock Acquisition Rights)
-
Holdings
Corporate
June 28, 2018
-
Notice Concerning Issuance of Stock Options (Stock Acquisition Rights)
-
Holdings
Corporate
May 14, 2018
-
"Notice Concerning Acquisition of Shares in Taisho Toyama Pharmaceutical Co., Ltd. (Conversion into a Wholly-Owned Subsidiary) and Sale of Shares in TOYAMA CHEMICAL CO., LTD."
-
Holdings
Corporate
May 14, 2018
-
Implementation of Early Retirement Program
-
Group Company
Corporate
October 13, 2017
-
Transfer of rights to anti-rheumatic agent KOLBET® Tablets in Japan
-
Holdings
Corporate
August 3, 2017
-
Notice Concerning Determination of Details of Stock Options
-
Holdings
Corporate
June 29, 2017
-
Notice Concerning Issuance of Stock Options (Stock Acquisition Rights)
-
Holdings
Corporate
January 31, 2017
-
"Notice Concerning the Termination of the Agreement Between Taisho Pharmaceutical Co., Ltd.
and Takeda Pharmaceutical Co., Ltd. on the Distribution of the OTC Drugs and Quasi-Drugs of Biofermin Pharmaceutical Co., Ltd."
-
Holdings
Corporate
December 26, 2016
-
Notice Concerning Acquisition of Dr. Program Co., Ltd., Consolidated Subsidiary of KYORIN Holdings, Inc.
-
Holdings
Corporate
August 2, 2016
-
Notice Concerning Determination of Details of Stock Options (Stock Acquisition Rights)
-
Holdings
Corporate
July 15, 2016
-
Signing of Licensing and Commercialization Agreement Regarding OTC Drug Products in Japan for the Allergy Treatment Claritin
-
Holdings
Corporate
July 5, 2016
-
Taisho Completes Acquisition of 24.50% Shares in Duoc Hau Giang Pharmaceutical JSC
-
Holdings
Corporate
June 29, 2016
-
Notice Concerning Issuance of Stock Options (Stock Acquisition Rights)
-
Holdings
Corporate
March 9, 2016
-
Status of Stock Buyback on Open Market, End of Buyback Program
-
Holdings
Corporate
March 1, 2016
-
Status of Stock Buyback on Open Market
-
Holdings
Corporate
February 3, 2016
-
Decision on Matters Concerning Stock Buyback
-
Group Company
Corporate
January 22, 2016
-
Agent for Osteoporosis Approved in Japan “Bonviva® Tablet”